Updated:
Nestlé Health Science SA
Nestlé Health Science SA is Nestlé's health-science subsidiary, led by Greg Behar, focusing on medical nutrition and therapeutic interventions since 2011.
Nestlé Health Science SA
Nestlé Health Science SA was established in 2011 as a wholly owned subsidiary of Nestlé SA, the world's largest food and beverage company by revenue. The unit is headquartered in Vevey, Switzerland, and is separate from Nestlé's traditional food divisions. Its founding CEO, Greg Behar, leads a team focused on translating nutritional science into clinical treatments. The firm's strategy spans three pillars: medical nutrition, vitamin and supplement brands, and therapeutic interventions. Its portfolio includes Atrium Innovations (acquired in 2017 for $2.3B, per company filings), Solgar vitamins, and a partnership with California-based Pendulum Therapeutics to develop microbiome-based treatments. Geographically, Nestlé Health Science operates across the Americas, Europe, and Asia. In early 2024, Nestlé Health Science launched a clinical trial for a nutritional intervention targeting metabolic syndrome. The unit employs roughly 9,000 people globally, per public filings, and maintains research hubs in Switzerland, the US, and Ireland. Adjacent structures include the Nestlé Research institute and the Nestlé Institute of Health Sciences. The structural differentiator is Nestlé Health Science's mandate to bridge the gap between fast-moving consumer goods and rigorous clinical evidence. Unlike typical family offices or venture capital, it can leverage Nestlé's global supply chain and regulatory infrastructure to scale therapeutic products from bench to shelf.
General information
Firm type
other
Year founded
2011
AUM
Undisclosed
Location
Region
Europe
Country
Switzerland
City
Vevey
Corporate office
Vevey, Switzerland
Principals
Greg Behar
CEO
Stephen Mihm
CFO
Sector focus
Frequently asked questions
Who runs investment decisions at Nestlé Health Science SA?
The CEO, Greg Behar, sets the strategic direction and leads the executive committee. Investment decisions are made collaboratively with Nestlé SA's corporate development team and the unit's scientific advisory board.
How does Nestlé Health Science SA source proprietary deal flow?
The firm relies on Nestlé's existing relationships in the food and pharmaceutical industries, often targeting companies with a strong scientific foundation in medical nutrition, vitamins, and probiotics. It has accessed academic spinouts through partnerships, such as the collaboration with UC San Diego on microbiome science.
Is Nestlé Health Science SA structured as a separate legal entity from Nestlé SA?
Yes, Nestlé Health Science SA is a standalone subsidiary with its own management and balance sheet. It operates under the Nestlé Group umbrella but has distinct revenue and R&D reporting. The unit's financials are consolidated into Nestlé SA's results.
What investment stages does Nestlé Health Science SA typically target?
The firm primarily acquires established brands and mid-stage therapeutic companies rather than early-stage startups. Notable acquisitions include Atrium Innovations (mature nutraceutical) and a controlling stake in Vital Proteins. It also makes minority investments in clinical-stage biotech through its venture arm.
Does Nestlé Health Science SA participate in fund commitments or only direct deals?
It primarily engages in direct acquisitions and partnerships. However, Nestlé SA's corporate venture unit, Nestlé Ventures, may co-invest alongside external funds, though this is not a core activity of Nestlé Health Science SA.
Which sectors does Nestlé Health Science SA explicitly avoid?
The firm avoids speculative biotech or drug-discovery bets that do not have a clear route to consumer or medical nutrition products. It also stays away from traditional pharmaceutical drug development, such as small-molecule therapies, focusing instead on dietary interventions and supplements.
Where does the underlying wealth come from?
Nestlé Health Science SA is funded by Nestlé SA, a publicly traded company founded in 1866 and valued at approximately $350 billion market cap as of 2025. Nestlé SA's revenue stream from global food and beverage sales provides the capital for this subsidiary.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: